# Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT01872962** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 480 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** gemcitabine and cisplatin (Induction chemotherapy)
- **RADIATION:** IMRT and concurrent cisplatin

## Key facts

- **NCT ID:** NCT01872962
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2018-11
- **Final completion:** 2020-11
- **Target enrollment:** 480 (ACTUAL)
- **Last updated:** 2018-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01872962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01872962, "Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01872962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*